Insmed Incorporated (INSM) — Fair Value Analysis
Base-case fair value (P50): $96.37 · Current price: $110.11 · Verdict: Fairly Valued
The Verdict on INSM
Our Monte Carlo simulations indicate Insmed Inc (INSM) is Fairly Valued at its current market price. While the stock currently trades at $110.11, our median fair value (P50) estimate stands at $96.37. This implies a -12.5% difference, suggesting the market's current valuation closely aligns with our probabilistic fair value assessment derived from thousands of forward-looking scenarios. The Fairly Valued verdict reflects this proximity, indicating neither a substantial discount nor a significant premium relative to its intrinsic value today.
How INSM stacks up against peers
Insmed Inc exhibits an average quality tier in terms of its operational and financial health. This "average" standing, a key input into our valuation models, suggests a balanced profile without extreme strengths or weaknesses that would drastically pull our fair value estimates away from the current market price. The market's perception of INSM's intrinsic value, as reflected in $110.11, appears to incorporate this average quality. While some companies may show greater volatility or more pronounced deviations between $110.11 and $96.37 due to exceptional quality or distress, INSM's average quality tier contributes to its Fairly Valued status, resulting in the modest -12.5%.
What this means for investors
For investors, the Fairly Valued assessment means that INSM's $110.11 largely reflects its intrinsic worth based on current fundamentals and future projections. While the -12.5% suggests a slight potential deviation, it does not flag INSM as a compelling deep-value opportunity nor as significantly overextended. Investors seeking substantial upside may need to consider scenarios beyond the median P50, such as a strong bull case, or weigh the potential downside if a bear case unfolds. FairCurve provides the full Monte Carlo distribution, including bear (P10) and bull (P90) targets, to help assess these probability-weighted scenarios. Sign up for FairCurve to see the full bear/bull distribution and track INSM's fair value as new fundamentals are released.
Frequently Asked Questions
Is INSM overvalued or undervalued right now?
Based on our Monte Carlo simulations, Insmed Inc (INSM) is currently Fairly Valued, with its current price of $110.11 closely aligned with our median fair value estimate (P50) of $96.37.
What is the bear case and bull case for INSM?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) targets for INSM, along with the probability of achieving various levels of upside, is available to subscribers with a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate INSM's fair value?
FairCurve calculates INSM's fair value using sophisticated Monte Carlo simulations that model thousands of forward-looking scenarios, accounting for various fundamental drivers and market conditions to arrive at a probabilistic fair value range.
How can I track INSM's fair value as it changes?
You can add INSM to your free FairCurve watchlist to receive daily fair-value updates. Our system instantly re-evaluates INSM's fair value whenever new earnings reports or significant fundamental data are released.